Manufacturing Agreement May 6, 2016Manufacturing Agreement • July 28th, 2016 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2016 Company IndustryWHEREAS, Client previously held the rights to the Product in the whole world other than the United States of America (“USA”) and Canada; and
AGREEMENT OF SUBLEASESublease Agreement • July 28th, 2016 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2016 Company IndustryTHIS AGREEMENT OF SUBLEASE (this “Sublease”), made as of June 22, 2016, between HUNTON & WILLIAMS LLP, a Virginia registered limited liability partnership (“Sublessor”), having an office at 2200 Pennsylvania Avenue, N.W., Washington, DC 20037, and VANDA PHARMACEUTICALS INC., a Delaware corporation (“Sublessee”), having an office at 2200 Pennsylvania Avenue, N.W., Washington, DC 20037, recites and provides:
AMENDMENT NO. 2 TO LEASELease • July 28th, 2016 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2016 Company IndustryTHIS AMENDMENT NO. 2 TO LEASE (“Amendment”) is made as of the 20th day of June 2016 (“Effective Date”), by and between SQUARE 54 OFFICE OWNER LLC, a Delaware limited liability company (“Landlord”), and VANDA PHARMACEUTICALS INC., a Delaware corporation (“Tenant”).